Driving discovery of next-gen biomarkers with novel immunoproteomics technologies and services.
Our immunoprofiling service enables profiling against more than 1800 disease relevant antigens with two simultaneous isotypes (IgG/IgA), capturing nearly 4000 data points.
Diversity. Precision. Specificity.
Alfatec Advanced Lab Solutions brings the Sengenics Microarray Technology to Italy
With over 30 years experience, Alfatech has been helping match Italian researchers with the tools they need to advance their aims and help the Italian community.
Visit Alfatec at:
Proteigene is an official distribution partner of Sengenics, the immunoproteomics company, for the French community. Proteigene has been working for more than 20 years in the proteomic research area and this partnership is an excellent opportunity to accelerate proteomics research and biomarker discovery.
Visit Proteigene’s website for more information about services in France:
What makes an ideal biomarker and how do you measure? Professor Blackburn recently shared his insights with Drug Discovery World.
Have a listen:
Dr. Osman’s group at NYU has successfully utilized the Sengenics protein microarray to identify autoantibody signatures predictive of both response (recurrence) and adverse outcomes from immune checkpoint inhibition for treatment of melanoma. She discussed her work with us and the benefits of functional protein microarrays to her research.
You can read the interview HERE.
Learn how to accelerate biomarker discovery with autoantibodies HERE
Our patented KREX® protein folding technology provides unique capabilities that accelerate the discovery of clinically relevant biomarkers.
Featured Service
Discover and validate new autoantibody biomarkers and biomarker signatures with unmatched specificity and reproducibility.
